Epstein‐Barr virus (EBV), a member of the herpesvirus family, causes infectious mononucleosis and is associated with human cancers, such as Burkitt and Hodgkin lymphomas, gastric carcinoma, and nasopharyngeal carcinoma. EBV establishes a latent infection in B cells, but must be reactivated into the viral lytic cycle to produce more virions and spread the infection among cells and hosts. The viral lytic cascade is initiated by the expression of two viral genes BZLF1 and BRLF1. The transcription of these viral immediate‐early genes is highly regulated. Reactivation of the viral lytic cycle is triggered by a variety of chemical and environmental stimuli. Chemical lytic inducing agents must alter cellular signaling pathways and transcription factors that control viral lytic gene expression. To discover cellular genes involved in viral reactivation, EBV‐positive cells were treated with activators or inhibitors of the viral lytic cycle. Changes in cellular gene expression were measured by next‐generation RNA sequencing (RNA‐seq). Transcriptome analysis identified large changes in expression of cellular genes involved in the redox status of the cell. Future work will connect these cellular pathways to the control of viral lytic gene expression.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Read full abstract